483 Carnegie Pharmaceutical Sep 2020

483 Carnegie Pharmaceutical Sep 2020

Frederick Razzaghi FDA$119.00 - Available Now

FDA investigators audited the Carnegie Pharmaceutical - Delran, NJ, United States facility and issued inspectional observations (via FDA 483) on 03 Sep 2020.

Product details

  • Category: Human Drugs
  • Inspection end: 03 Sep 2020
  • Location: Delran, United States
  • FEI: 3011603634
Add To Cart